Squawkbox On The Radar 07-11-08

Description: plays for potential upside. One stock on our list is OSI Pharmaceuticals. It has multiple data releases expected in the second half of 2008 that can be major catalysts to send this stock higher. Tarceva, used for treatment of non-small cell lung cancer, has shown indications to potentially become the leading drug in this area, and has a huge market opportunity. The company also has BETA and SATURN in the works that could also become big players in oncology. Management has shown the ...